Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Jennifer M, Bird"'
Publikováno v:
InnovAiT: Education and inspiration for general practice. 14:415-421
Myeloma is a rare, life-limiting blood cancer arising from plasma cells. Early diagnosis is imperative to improve clinical outcomes for patients, by both improving overall survival and reducing the morbidity associated with myeloma-related end-organ
Autor:
Sam H, Ahmedzai, John A, Snowden, Andrew John, Ashcroft, David Allan, Cairns, Cathy, Williams, Anna, Hockaday, Jamie D, Cavenagh, Debo, Ademokun, Eleni, Tholouli, David, Allotey, Vijay, Dhanapal, Matthew, Jenner, Kwee, Yong, Jim, Cavet, Hannah, Hunter, Jennifer M, Bird, Guy, Pratt, Christopher, Parrish, Julia M, Brown, Treen C M, Morris, Gordon, Cook
Publikováno v:
Journal of Clinical Oncology
J Clin Oncol
J Clin Oncol
PURPOSE Salvage autologous stem-cell transplantation (sASCT) in patients with multiple myeloma (MM) relapsing after a prior autologous stem-cell transplantation leads to increased remission duration and overall survival. We report a comprehensive stu
Autor:
Bryony Dawkins, Amy Beth Coulson, Mark T. Drayson, Martin Kaiser, David Meads, Sharon Gillson, Phillip Best, Neil Rabin, Roger G. Owen, Catherine Olivier, John R Jones, Christopher Parrish, David A Cairns, Kara-Louise Royle, Charlotte Pawlyn, Jennifer M. Bird, Stella Bowcock, Gordon Cook, Rowena Henderson, Graham Jackson, Ruth M. de Tute, Matthew W Jenner, Bhuvan Kishore
Publikováno v:
Blood. 138:81-81
Background Although the median age of patients with newly diagnosed multiple myeloma (MM) is 70-74 years, recruitment of frail older patients to clinical trials is poor. The International Myeloma Working Group (IMWG) frailty score predicts survival,
Autor:
Mei-Jie Zhang, Vivek Roy, Shaji Kumar, Angela Dispenzieri, Dan T. Vogl, Jiaxing Huang, Baldeep Wirk, Parameswaran Hari, Daniel J. Landsburg, Robert Peter Gale, Muneer H. Abidi, Xiaobo Zhong, Tamila L. Kindwall-Keller, Jennifer M. Bird, Ravi Vij, Reinhold Munker, Manish Sharma, Hillard M. Lazarus, Robert A. Kyle, Cesar O. Freytes
Publikováno v:
Biology of Blood and Marrow Transplantation. 21(2):335-341
Patients with multiple myeloma (MM) who are eligible for autologous stem cell transplantation (ASCT) typically receive a finite period of initial therapy before ASCT. It is not clear if patients with suboptimal (less than a partial) response to initi
Publikováno v:
British journal of haematology. 179(1)
Autor:
Kwee Yong, Abigail Fisher, Monica Morris, Guy Pratt, John A. Snowden, Jennifer M. Bird, Diana Greenfield, Eric Low, Elaine G. Boland, Stella Bowcock
Publikováno v:
British journal of haematology. 176(6)
A growing population of long-term survivors of myeloma is now accumulating the 'late effects' not only of myeloma itself, but also of several lines of treatment given throughout the course of the disease. It is thus important to recognise the cumulat
Autor:
A. Wechalaker, Faith E. Davies, Kwee Yong, Neil Rabin, S. Bowcock, M. Lai, Jennifer M. Bird, Gordon Cook, John A. Snowden, Roger G. Owen, E. Low, Gareth J. Morgan, Guy Pratt
Publikováno v:
International Journal of Laboratory Hematology. 36:665-675
Therapeutic advances and the availability of novel agents have significantly improved outcomes in myeloma; yet, it remains incurable and strategies to improve survival continue to be sought. One approach is to prolong the duration of response and inc
Autor:
Faith E. Davies, John A. Snowden, Sue E. Bell, Roger G. Owen, M. Lai, Gareth J. Morgan, Kwee Yong, S. Bowcock, James D. Cavenagh, Shirley D'Sa, Gary Cook, Jennifer M. Bird, Guy Pratt
Publikováno v:
International Journal of Laboratory Hematology. 36:20-28
Bendamustine is a unique bifunctional alkylating agent with promising activity in myeloma. Despite the increasing number of studies demonstrating its efficacy in both the upfront and relapse settings, including patients with renal insufficiency, the
Autor:
Peigang Li, Robert A. Kyle, Angela Dispenzieri, Jennifer M. Bird, Joseph R. Mikhael, Sagar Lonial, Anuj Mahindra, Steven Saccaro, Mei-Jie Zhang, Dan T. Vogl, Rajneesh Nath, Leona Holmberg, David H. Vesole, Robert Peter Gale, Jorge Vela-Ojeda, Parameswaran Hari, Baldeep Wirk, Shaji Kumar, Gustavo Milone, L. Bik To, Hillard M. Lazarus, Matt Kalaycio, Reinhold Munker, James Gajewski, James R. Berenson
Publikováno v:
Leukemia
There are limited data on hematopoietic cell transplantation (HCT) in primary plasma cell leukemia (pPCL), an aggressive plasma cell disorder. We report outcomes of 147 patients with pPCL receiving autologous (n=97) or allogeneic (n=50) HCT within 18
Autor:
Sylvia Feyler, Eric Low, Guy Pratt, John A. Snowden, Gordon Cook, UK Myeloma Forum, Roger G. Owen, Jennifer M. Bird, Jamie Cavenagh, Gareth J. Morgan, Kwee Yong, John Ashcroft, Faith E. Davies, Shirley D'Sa, Judith Behrens
Publikováno v:
British Journal of Haematology. 154:32-75
653. Spencer, A., Prince, H.M., Roberts, A.W., Prosser, I.W., Bradstock, K.F., Coyle, L., Gill, D.S., Horvath, N., Reynolds, J. & Kennedy, N. (2009) Consolidation therapy with low-dose thalido- mide and prednisolone prolongs the survival of multiple